Alerts will be sent to your verified email
Verify Email
BIOGEN
|
Biogen Pharmachem
|
Danube Industries
|
Welcure Drugs&Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.19 % | 5.99 % | 43.2 % |
|
5yr average Equity Multiplier
|
1.01 | 3.55 | -0.38 |
|
5yr Average Asset Turnover Ratio
|
0.02 | 1.58 | 0.25 |
|
5yr Avg Net Profit Margin
|
-19.83 % | 1.38 % | -80.17 % |
|
Price to Book
|
0.67 | 1.89 | 0.5 |
|
P/E
|
38.35 | 46.45 | 1.92 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 96.69 Days | 2364.01 Days |
|
Inventory Days
|
0.0 | 31.14 Days | 20.66 Days |
|
Days Receivable
|
0.0 | 83.28 Days | 1232.42 Days |
|
Days Payable
|
3.0 Days | 119.36 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
902.8 | 106.77 | -2.67 |
|
5yr Avg ROCE
|
0.2 % | 10.05 % | -7.19 % |
|
5yr Avg Operating Profit Margin
|
-19.88 % | 2.07 % | -81.01 % |
|
5 yr average Debt to Equity
|
0.0 | 0.48 | -0.35 |
|
5yr CAGR Net Profit
|
-28.94 % | 28.37 % | -2.01 % |
|
5yr Average Return on Assets
|
0.19 % | 2.12 % | -1.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 39.93 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 5.56 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biogen Pharmachem
|
Danube Industries
|
Welcure Drugs&Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|